Variation of the N-acetyltransferase 2 gene in a Romanian and a Kyrgyz population

被引:15
作者
Rabstein, S
Unfried, K
Ranft, U
Illig, T
Kolz, M
Rihs, HP
Mambetova, C
Vlad, M
Brüning, T
Pesch, B
机构
[1] Inst Ruhr Univ Bochum, Berufsgenossenschaftliches Forschungsinst Arbeits, D-44789 Bochum, Germany
[2] Univ Dusseldorf GmbH, Inst Umweltmed Forsch, D-4000 Dusseldorf, Germany
[3] GSF Natl Res Ctr Environm & Hlth, Inst Epidemiol GmbH, Neuherberg, Germany
[4] Kyrgyz Sci Ctr Hematol, Bishkek, Kyrgyzstan
[5] Inst Publ Hlth Iuliu Moldovan, Cluj Napoca, Romania
关键词
D O I
10.1158/1055-9965.EPI-05-0256
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
As part of a project on environmental disasters in minority populations, this study aimed to evaluate differences in the sequence of N-acetyltransferase 2 (NAT2) as a metabolic susceptibility gene in yet unexplored ethnicities. Eight single nucleotide polymorphisms (SNP) in the NAT2 coding region and a variant in the 3' flanking region were analyzed in 290 unrelated Kyrgyz and 140 unrelated Romanians by SNP-specific PCR analysis. The variants 341C, 481T, and 803G were less and 857A more prevalent in Kyrgyz (P < 0.0001). The variant at site 857 indicates Asian descent. 282C>T and 590G>A showed no significant variation by ethnicity. 364G>A and 411A>T turned out to be monomorphic. Database comparisons of the NAT2 minor allele frequencies support that Romanians belong to Caucasians and Kyrgyz are in between Caucasians and East Asians. The distributions of predicted haplotypes differed significantly between the two ethnicities where the Kyrgyz showed a higher genetic diversity. The haplotype without mutations was more common in Kyrgyz (40.1% in Kyrgyz, 29.3% in Romanians). Accordingly, the imputed slow acetylator phenotype was less prevalent in Kyrgyz (35.2% versus 51.4% in Romanians). We found pronounced ethnic differences in NAT2 genotypes with yet unknown effect on the health risks for environmental or occupational exposures in minority populations.
引用
收藏
页码:138 / 141
页数:4
相关论文
共 24 条
[1]  
Agundez JAG, 1996, PHARMACOGENETICS, V6, P423
[2]   Pitfalls in N-acetyltransferase 2 genotyping [J].
Cascorbi, I ;
Roots, I .
PHARMACOGENETICS, 1999, 9 (01) :123-127
[3]  
CASCORBI I, 1995, AM J HUM GENET, V57, P581
[4]  
Deitz AC, 2004, CANCER EPIDEM BIOMAR, V13, P1543
[5]   Genotyping of the polymorphic N-acetyltransferase (NAT2*) gene locus in two native African populations [J].
Delomenie, C ;
Sica, L ;
Grant, DM ;
Krishnamoorthy, R ;
Dupret, JM .
PHARMACOGENETICS, 1996, 6 (02) :177-185
[6]  
Garte S, 2001, CANCER EPIDEM BIOMAR, V10, P1239
[7]  
Gross M, 1999, CANCER EPIDEM BIOMAR, V8, P683
[8]  
Hein DW, 2000, CANCER EPIDEM BIOMAR, V9, P29
[9]   Whole-genome patterns of common DNA variation in three human populations [J].
Hinds, DA ;
Stuve, LL ;
Nilsen, GB ;
Halperin, E ;
Eskin, E ;
Ballinger, DG ;
Frazer, KA ;
Cox, DR .
SCIENCE, 2005, 307 (5712) :1072-1079
[10]   Analysis of six SNPs of NAT2 in Ngawbe and Embera Amerindians of Panama and determination of the Embera acetylation phenotype using caffeine [J].
Jorge-Neberta, LF ;
Eichelbaum, M ;
Griese, EU ;
Inaba, T ;
Arias, TD .
PHARMACOGENETICS, 2002, 12 (01) :39-48